With medical advances, many of the diseases in reducing mortality, but chronic obstructive pulmonary disease mortality is on the rise.
COPD has been considered to be male disease, it is because COPD is the primary risk factors in smoking working environment and in contact with pollutants, especially particulates. In a fairly long period of time, these risk factors actually only in the role of men.
With the increase in women smoking, occupational exposure to harmful factors are increasing, now, the female prevalence of COPD of a recovery.
Early diagnosis of COPD patients rate is very low, with? A href = 'http://lx.jibingku.com/' target = _blank> Jin Shi ⒆ of blowing Mou ∪ Deng Ping Xiang Zi Hey δ觳spinulosa: Dusou ∪ Shortage of people Mo Dang Jin Chen Zheng affect cloud sent Di Shi blast with carcasses if aphid »
At present, the clinical diagnosis of COPD term confusion, some known as emphysema, and some referred to as chronic bronchitis, this will affect the patient's diagnosis, illness has also affected the number of statistics.
COPD is usually in the 55-year-old was diagnosed, the earlier loss of labor.
COPD is common diseases and frequently-occurring disease, the treatment of certain difficulties. China's current prevention and treatment of COPD degree of attention is far from enough.
According to the Ministry of Health statistics, 2001, respiratory disease out of China's urban population mortality rate of the fourth, second only to cancer, cerebrovascular disease and cardiovascular disease, and died of respiratory diseases as COPD or with the overwhelming majority of the COPD, COPD is still listed the cause of death in rural areas first. COPD has become a major public health impact of the disease.
Smoking is the major risk factors for COPD has long been one of clear, but China's anti-smoking efforts is far from enough, young people, women smoking rate remains high. To fundamentally control the disease, people should consciously quit smoking as soon as possible. Because smoking cessation is an effective measures to delay the progress of COPD.
At present for the treatment of COPD is the primary drug of bronchodilators such as aminophylline, although the effect of its expansion bronchial weak, but it can be significantly improved in patients with mild symptoms and lung over-inflated, intermittent applications; moderate COPD patients Should consider the use of bronchiectasis; severe and very severe COPD patients should consider using inhaled glucocorticoids, and increases with low-flow oxygen inhalation.
5/1/08
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment